Chiara M. Eandi

4.5k total citations
109 papers, 3.0k citations indexed

About

Chiara M. Eandi is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Chiara M. Eandi has authored 109 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Ophthalmology, 60 papers in Radiology, Nuclear Medicine and Imaging and 15 papers in Molecular Biology. Recurrent topics in Chiara M. Eandi's work include Retinal Diseases and Treatments (83 papers), Retinal Imaging and Analysis (42 papers) and Retinal and Optic Conditions (40 papers). Chiara M. Eandi is often cited by papers focused on Retinal Diseases and Treatments (83 papers), Retinal Imaging and Analysis (42 papers) and Retinal and Optic Conditions (40 papers). Chiara M. Eandi collaborates with scholars based in Italy, Switzerland and United States. Chiara M. Eandi's co-authors include Felice Cardillo Piccolino, Luca Ventre, Federico Grignolo, Lawrence A. Yannuzzi, Camilla Alovisi, Richard F. Spaide, Michael D. Ober, Claudio Bucolo, A. El Maftouhi and José‐Alain Sahel and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Chiara M. Eandi

102 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara M. Eandi Italy 29 2.6k 1.4k 626 209 151 109 3.0k
Shozo Sonoda Japan 31 2.3k 0.9× 1.7k 1.2× 923 1.5× 98 0.5× 258 1.7× 118 3.2k
Luca Agnifili Italy 33 2.2k 0.9× 1.6k 1.2× 334 0.5× 101 0.5× 123 0.8× 102 2.8k
Takeshi Iwase Japan 26 1.3k 0.5× 971 0.7× 541 0.9× 63 0.3× 58 0.4× 110 1.8k
Marcus Kernt Germany 30 1.8k 0.7× 1.1k 0.8× 868 1.4× 67 0.3× 115 0.8× 109 2.6k
Marco Ciancaglini Italy 33 2.1k 0.8× 1.8k 1.3× 259 0.4× 97 0.5× 234 1.5× 102 2.8k
K V Chalam United States 26 1.6k 0.6× 1.1k 0.8× 421 0.7× 68 0.3× 99 0.7× 106 2.0k
Daniel Pauleikhoff Germany 37 4.8k 1.8× 3.1k 2.2× 1.7k 2.7× 88 0.4× 102 0.7× 208 5.4k
Claudia N. Keilhauer Germany 18 2.0k 0.8× 1.2k 0.9× 1.4k 2.2× 64 0.3× 225 1.5× 32 2.9k
Aristomenis Thanos United States 22 949 0.4× 704 0.5× 655 1.0× 99 0.5× 29 0.2× 66 1.7k
Nancy M. Holekamp United States 31 2.8k 1.1× 2.2k 1.6× 875 1.4× 36 0.2× 39 0.3× 91 3.3k

Countries citing papers authored by Chiara M. Eandi

Since Specialization
Citations

This map shows the geographic impact of Chiara M. Eandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara M. Eandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara M. Eandi more than expected).

Fields of papers citing papers by Chiara M. Eandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara M. Eandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara M. Eandi. The network helps show where Chiara M. Eandi may publish in the future.

Co-authorship network of co-authors of Chiara M. Eandi

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara M. Eandi. A scholar is included among the top collaborators of Chiara M. Eandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara M. Eandi. Chiara M. Eandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Desideri, Lorenzo Ferro, et al.. (2026). Drusen-specific dark adaptation profiles in intermediate age-related macular degeneration. International Journal of Retina and Vitreous. 12(1). 34–34.
2.
3.
Berni, Alessandro, Chiara M. Eandi, Pasquale Viggiano, et al.. (2025). Quantifying macular atrophy in neovascular AMD using en face structural OCT imaging. Eye. 39(13). 2534–2539.
4.
Montesel, Andrea, et al.. (2025). Early real-world outcomes of intravitreal aflibercept 8 mg in treatment-Naïve neovascular AMD: AI-assisted fluid volume analysis. International Journal of Retina and Vitreous. 11(1). 42–42. 2 indexed citations
5.
Michels, Stephan, et al.. (2024). Aflibercept high-dose (8mg) related intraocular inflammation (IOI) – a case series. BMC Ophthalmology. 24(1). 520–520. 8 indexed citations
6.
Martin, Thibaud, et al.. (2024). Importance of OCT-derived biomarkers for the recurrence of central serous chorioretinopathy using statistics and predictive modelling. Scientific Reports. 14(1). 23940–23940. 2 indexed citations
7.
Giunta, Salvatore, Agata Grazia D’Amico, Grazia Maugeri, et al.. (2023). Drug-Repurposing Strategy for Dimethyl Fumarate. Pharmaceuticals. 16(7). 974–974. 3 indexed citations
8.
Garweg, Justus G., C Blum, Chiara M. Eandi, et al.. (2023). Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects. Ophthalmology and Therapy. 12(2). 639–655. 8 indexed citations
9.
Vadalà, Maria, et al.. (2022). Early OCTA Changes of Type 3 Macular Neovascularization Following Brolucizumab Intravitreal Injections. Medicina. 58(9). 1180–1180. 8 indexed citations
10.
Fallico, Matteo, Andrew Lotery, Antonio Longo, et al.. (2020). Treat and extend versus fixed regimen in neovascular age related macular degeneration: A systematic review and meta-analysis. European Journal of Ophthalmology. 31(5). 2496–2504. 10 indexed citations
11.
Alovisi, Camilla, Claudio Panico, Ugo de Sanctis, & Chiara M. Eandi. (2017). Vitreous Substitutes: Old and New Materials in Vitreoretinal Surgery. Journal of Ophthalmology. 2017. 1–6. 50 indexed citations
12.
Sanctis, Ugo de, et al.. (2017). Corneal Astigmatism Measurement by Ray Tracing Versus Anterior Surface–Based Keratometry in Candidates for Toric Intraocular Lens Implantation. American Journal of Ophthalmology. 177. 1–8. 9 indexed citations
13.
Giurdanella, Giovanni, Francesca Lazzara, Nunzia Caporarello, et al.. (2017). Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE. Biochemical Pharmacology. 142. 145–154. 49 indexed citations
14.
Guillonneau, Xavier, Chiara M. Eandi, Michel Pâques, et al.. (2017). On phagocytes and macular degeneration. Progress in Retinal and Eye Research. 61. 98–128. 129 indexed citations
15.
Eandi, Chiara M., Camilla Alovisi, Ugo de Sanctis, & Federico Grignolo. (2016). Treatment for neovascular age related macular degeneration: The state of the art. European Journal of Pharmacology. 787. 78–83. 25 indexed citations
16.
Bottoni, Ferdinando, et al.. (2010). INTEGRATED CLINICAL EVALUATION OF TYPE 2A IDIOPATHIC JUXTAFOVEOLAR RETINAL TELANGIECTASIS. Retina. 30(2). 317–326. 27 indexed citations
17.
Eandi, Chiara M., Michael D. Ober, K. Bailey Freund, Jason S. Slakter, & Lawrence A. Yannuzzi. (2007). SELECTIVE PHOTODYNAMIC THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH POLYPOIDAL CHOROIDAL NEOVASCULARIZATION. Retina. 27(7). 825–831. 59 indexed citations
18.
Eandi, Chiara M., et al.. (2005). Subretinal Fluid in Best’s Vitelliform Macular Dystrophy Associated With Abnormalities of Fundus Autofluorescence. Investigative Ophthalmology & Visual Science. 46(13). 553–553. 1 indexed citations
19.
Eandi, Chiara M., et al.. (2005). OPTICAL COHERENCE TOMOGRAPHY IN UNILATERAL RESOLVED CENTRAL SEROUS CHORIORETINOPATHY. Retina. 25(4). 417–421. 97 indexed citations
20.
Piccolino, Felice Cardillo, et al.. (2002). RETINAL TOXICITY FROM ACCIDENTAL INTRAOCULAR INJECTION OF DEPO-MEDROL. Retina. 22(1). 117–119. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shozo Sonoda Breakdown of academic impact, for papers by Luca Agnifili Breakdown of academic impact, for papers by Takeshi Iwase Breakdown of academic impact, for papers by Marcus Kernt Breakdown of academic impact, for papers by Marco Ciancaglini Breakdown of academic impact, for papers by K V Chalam Breakdown of academic impact, for papers by Daniel Pauleikhoff Breakdown of academic impact, for papers by Claudia N. Keilhauer Breakdown of academic impact, for papers by Aristomenis Thanos Breakdown of academic impact, for papers by Nancy M. Holekamp
Rankless by CCL
2026